Nasdaq GlobeNewswire

Sky9 Capital Announces the Addition of Chay, Teh, Xu, and Zeng to its Advisory Board

Del

HONG KONG, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Sky9 Capital, a leading China venture capital firm, announced that China industry veterans KS Chay, Dr. Kok Peng Teh, Bob Xu, and Jason Zeng have joined its Advisory Board to provide strategic advice and foster long-term partnerships.

KS Chay is Founder and Chairman of Enspire Capital, and previously he co-founded Singapore's first Nasdaq-listed technology company, Creative Technology Ltd (SGX:C76). Dr. Kok Peng Teh is currently Senior Advisor and Board Member for China International Capital Corporation, and he was President of Government of Singapore Special Investments (GIC) for over a decade until 2011. Mr. Bob Xu co-founded New Oriental Education & Technology Group (NYSE:EDU), the largest provider of private education in China, and is one of China's most successful angel investors having founded ZhenFund in 2010. Mr. Jason Zeng co-founded Tencent Holdings Ltd (HK:0700) and is currently Chairman of the angel-stage investment firm Decent Capital.

"We are honored to have industry veterans like KS Chay, Dr. Kok Peng Teh, Bob Xu, and Jason Zeng join our firm as our board of advisors," said Ron Cao, Founder and Managing Director of Sky9 Capital. "Mr. Chay and Dr. Teh come from a strong institutional approach to investing and can provide us with great guidance on how to continue to build out our organization. Bob and Jason are two of China's most successful entrepreneurs, so we gain great insights from their operational background as well as inspiration on how to build great businesses together with entrepreneurs."

Founded by China venture capital veteran Ron Cao, Sky9 Capital's mission is to partner with the next generation of entrepreneurs to create world-class companies that also have societal impact. With over 17 years of VC experience in both the US and China, Ron has invested in some of China's leading technology companies including: Tujia, China's largest AirBnB player; FangDuoDuo, China's largest online-to-offline real estate transaction platform; PPDai, China's largest pure-play microlending platform; and QingCloud, China's leading enterprise-grade cloud computing platform.  Ron has been named by Forbes China as one of China's "Top Venture Capitalists" over multiple years and is honored by the World Economic Forum as one of its "Young Global Leaders".

Sky9 Capital's senior team consists of additional partners with strong venture capital and start-up experience. The team of Wei Hao, Jing Wang, Jonathan Qiu, and Tony Lo, have collectively over 30 years of venture capital experience in the US and China, and they previously worked at world-class technology companies such as Intel, Trilogy, Cisco, and Tencent. Their investments include PinDuoDuo, FaceU, Rong360, ZhaoGangWang, MaMaDaV, FangDuoDuo, JuMei, JingFuZhi, LuckyPai, and Dianping.

Sky9 Capital has completed six investments in its new fund, including ZhaoYouWang, the largest B2B marketplace for petroleum-related products in China; EZbuy, the leading Chinese cross-border e-commerce platform targeting the Southeast Asia market; and eBroker, the leading online platform for wealth management.

About Sky9 Capital 
Sky9 Capital is a leading early-stage China-focused technology venture capital firm. With its mission to partner with bold innovators to build world-class companies together and to make a positive impact on the world, Sky9 Capital specializes in the consumer Internet, enterprise, and deep technology sectors.  With presence in Beijing, Shanghai, Shenzhen, and Silicon Valley, our firm approaches investing with a global perspective and selectively partners with early-stage companies that have exceptional founding teams, disruptive and scalable business models, or innovative and transformational technology. For more information, please visit www.sky9capital.com.

Contact: Anthony Lo
Phone Number: +86-21-5238-3699
Email: tony@sky9capital.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sky9 Capital via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

CORRECTION - Elite Petro & Gas broadens financial services and signs a deal with Tabarak Investment Capital Limited18.10.2018 23:35Pressemelding

DUBAI, United Arab Emirates, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Today the President of Elite Petro & Gas, Mr. George Matharu and the President of Tabarak Investment Capital Limited (Investment Bank), Dr. Mohamed Ahmadi announced a deal in which the two companies will use their combined resources to execute physical commodity trades, and provide banking and finance facilities for oil and gas transactions. The alliance between the two entities will also allow compliance related activities to be carried out from two major international hubs of London and Dubai. This increases the international presence of both companies. Additionally, Elite Petro & Gas (“EPG”) has recently formed relationships with the owners of a number of high profile European, South American and Chinese projects, which EPG and Tabarak can work on together. Tabarak Investment Capital Limited is a regulated investment bank by Dubai Financial Services Authority and incorporated in the Dubai International Financial Centre.

Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21Pressemelding

BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03Pressemelding

NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can

Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00Pressemelding

SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part

Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30Pressemelding

EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our

SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call   18.10.2018 13:30Pressemelding

MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom